IGF2BP1 and cancer: The five-year TCGA survival analysis data shows significant differences between low and high IGF2BP1 expression patients (p = 0.0015) (Supplementary Figure S4A–C) https://www.proteinatlas.org/ENSG00000159217-IGF2BP1/pathology/renal+cancer (accessed on 15 March 2023).